| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f139134ea7f17af1883dedaecaf43b0a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-733 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-733
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L29-244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
| filingDate |
2004-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_517e4c284cb839860d4e84459d716e8a |
| publicationDate |
2009-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1696937-B1 |
| titleOfInvention |
Prebiotic combination products |
| abstract |
Prebiotic combination products and especially chewable tablets as the preferred dosage form are described with high acceptability for the prophylaxis and treatment of inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), calcium and magnesium deficiency including osteoporosis, food intolerances, the regulation of the digestion, stimulation of the immune system, energy management, prophylaxis of colon cancer and protection of the gut microbial ecosystem in man. A prebiotic combination of inulin/oligofructose and resistant starch in very low amounts has been found to give a prebiotic effect. The low dosage of the two prebiotic components makes it possible to formulate inexpensive dosage forms with good compliance due to a small amount of ingredients. The small amount of the prebiotics also result in a virtually absence of side-effects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102008059070-A1 |
| priorityDate |
2003-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |